March 6, 2026 — Belly of the Beast
More than seven million people in the U.S. are estimated to suffer from Alzheimer’s, a disease that systematically destroys a person’s memory, personality and ability to function. While there is no cure, there’s reason for hope. Despite being battered by a severe economic crisis fueled by U.S. sanctions, a group of patients from the U.S recently traveled to Cuba to access a promising medication called NeuralCIM.
Studies indicate that, unlike other medications, NeuralCIM has managed to slow the disease’s progression over an extended period of time without significant side effects, and has even reversed symptoms in some cases.
Colorado physician Dr. Bill Blanchet has accompanied his patients to Havana and says the impact of NeuralCIM, in just six months, has been life-changing.
“Making this drug available to the rest of the world is a mandate. It’s not a wish,” Blanchet told Belly of the Beast. “It will change the world.”
Belly of the Beast’s upcoming documentary, Teresita’s Dream, tells the story of Dr. Teresita Rodríguez, a Cuban scientist who helped develop NeuralCIM while caring for her mother as she lived with the disease.
“It would be very unfair if this product couldn’t reach other parts of the world,” Teresita says in the documentary. “It’s frustrating to think this could happen because of politics.”
